Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Feb 25;15(2):e35449.
doi: 10.7759/cureus.35449. eCollection 2023 Feb.

Hypertension Control Cascade and Regional Performance in India: A Repeated Cross-Sectional Analysis (2015-2021)

Affiliations

Hypertension Control Cascade and Regional Performance in India: A Repeated Cross-Sectional Analysis (2015-2021)

Saurav Basu et al. Cureus. .

Abstract

Background The weak control cascade of hypertension from the time of screening till the attainment of optimal blood pressure (BP) control is a public health challenge, particularly in resource-limited settings. The study objectives were to (1) estimate the change in the rate of prevalence of hypertension, the yield of newly diagnosed cases, initiation of treatment, and attainment of BP control in the age group 15 to 49 years; (2) ascertain the magnitude and predictors of undiagnosed hypertension, lack of initiation of treatment, and poor control of those on antihypertensive therapy; and (3) estimate the regional variation and state-level performance of the hypertension control cascade in India. Methodology We analyzed demographic and health surveillance (DHS) data from India's National Family Health Survey Fifth Series (NFHS-5), 2019-2021, and NFHS-4 (2015-2016). The NFHS-5 sample comprised 695,707 women and 93,267 men in the age group of 15 to 49 years. Multiple logistic regressions were performed to find the associated predictors, and respective adjusted odds ratios (aORs) were reported. Results The prevalence of hypertension (cumulative previously diagnosed and new cases) among individuals aged 15 to 49 years was 22.8% (22.6%, 23.1%; n = 172,532), out of which 52.06% were newly diagnosed cases. In contrast, in NFHS-4, the prevalence of hypertension among individuals aged 15 to 49 years was 20.4% (20.2%, 20.6%; n = 153,384), of which 41.65% were newly diagnosed cases. In NFHS-5, 40.7% (39.8% and 41.6%) of the previously diagnosed cases were on BP-lowering medications compared to 32.6% (31.8%, 33.6%) in NFHS-4. Furthermore, in NFHS-5, controlled BP was observed in 73.7% (72.7% and 74.7%) of the patients on BP-lowering medication compared to 80.8% (80.0%, 81.6%) in NFHS-4. Females compared to males (aOR = 0·72 and 0·007), residents of rural areas (aOR = 0·82 and 0·004), and those belonging to the socially disadvantaged groups were not initiated on treatment despite awareness of their hypertension status indicative of poor treatment-seeking behavior. Furthermore, increasing age (aOR = 0·49, P < 0·001), higher body mass index (aOR = 0·51, P < 0·001), and greater waist-to-hip ratio (aOR = 0·78, P = 0·047) were associated with uncontrolled hypertension in patients on antihypertensive drug therapy. Conclusions Hypertension control cascade in India is largely ineffectual although screening yield and initiation of antihypertensive treatment have improved in NFHS-5 compared to NFHS-4. Identification of high-risk groups for opportunistic screening, implementing community-based screening, strengthening primary care, and sensitizing associated practitioners are urgently warranted.

Keywords: blood pressure control; drug access; hypertension; medication adherence; nfhs; survey research.

PubMed Disclaimer

Conflict of interest statement

The authors have declared that no competing interests exist.

Figures

Figure 1
Figure 1. Prevalence of hypertension awareness, treatment, and control across states in India (NFHS-4, 2015-2016).
Figure credits: All the authors of this study. NFHS-4, National Family Health Survey Fourth Series
Figure 2
Figure 2. Prevalence of hypertension awareness, treatment, and control across states in India (NFHS-5, 2019-2021).
Figure credits: All the authors of this study. NFHS-5, National Family Health Survey Fifth Series

References

    1. Hypertension - Fact Sheet. [ Jan; 2023 ]. 2021. https://www.who.int/news-room/fact-sheets/detail/hypertension https://www.who.int/news-room/fact-sheets/detail/hypertension
    1. Global and national high blood pressure burden and control. Nguyen TN, Chow CK. Lancet. 2021;398:932–933. - PubMed
    1. GBD Compare. [ Jan; 2023 ]. 2023. http://vizhub.healthdata.org/gbd-compare http://vizhub.healthdata.org/gbd-compare
    1. Global disparities of hypertension prevalence and control: a systematic analysis of population-based studies from 90 countries. Mills KT, Bundy JD, Kelly TN, et al. Circulation. 2016;134:441–450. - PMC - PubMed
    1. Emerging trends in hypertension epidemiology in India. Gupta R, Gaur K, S Ram CV. J Hum Hypertens. 2019;33:575–587. - PubMed

LinkOut - more resources